Transcriptomics

Dataset Information

0

ColXα1 and Tumor Infiltrating Lymphocytes: a Marker of Response to Neoadjuvant Therapy in Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer


ABSTRACT: This study focused on patients with estrogen receptor positive/human epidermal growth factor receptor 2 positive (ER+/HER2+) breast cancer treated with neoadjuvant chemotherapy and HER2-targeted therapy (NAC+H), and was designed to identify novel biomarkers by correlating gene expression, histology and immunohistochemistry with pathologic response. We performed gene expression profiling on 11 pre-treatment tumors samples: 5 who had no or minimal residual disease residual cancer burden (RCB) score of 0 or 1 and 6 who had significant residual disease (RCB score of 2 or 3).

ORGANISM(S): Homo sapiens

PROVIDER: GSE67982 | GEO | 2015/09/08

SECONDARY ACCESSION(S): PRJNA281505

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-09-08 | E-GEOD-67982 | biostudies-arrayexpress
2012-01-13 | E-GEOD-22226 | biostudies-arrayexpress
| phs001291 | dbGaP
2012-01-13 | GSE22226 | GEO
2016-03-31 | E-GEOD-62327 | biostudies-arrayexpress
2012-05-11 | E-GEOD-37946 | biostudies-arrayexpress
2011-05-11 | E-GEOD-25065 | biostudies-arrayexpress
2011-05-11 | E-GEOD-25055 | biostudies-arrayexpress
2016-07-01 | GSE63471 | GEO
2012-03-20 | E-GEOD-32646 | biostudies-arrayexpress